Welcome to our Evotec Blog.

Hope you will find our articles and resources relevant for your projects and interests.

Our experts are available for any additional information and to assist with your project challenges!

Just contact us.




New Research by Cyprotex on Transporter DDI Published in Pharmacology Research & Perspectives
Laura Catalina, 31 October 2017

New research by Cyprotex in the field of metformin drug-drug interactions has been published in Pharmacology Research & Perspectives. The publication assists in further understanding the mechanism behind clinically observed DDIs with the common co-medication, metformin. Read our blog and download the publication. Cyprotex offers a full range of ...

Evotec and Tesaro Enter Strategic Partnership To Discover Novel Immuno-Oncology Agents
Laura Catalina, 26 October 2017

Discovery and development of inhibitors against Tesaro's Immuno-Oncology target utilising Evotec's comprehensive discovery and development platform Hamburg, Germany, 26 October 2017: Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) and TESARO, Inc. (“TESARO”) today announced a three-year integrated drug discovery collaboration...

Evotec Achieves First Milestone In Neurodegeneration Alliance With Celgene
Laura Catalina, 10 October 2017

Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) announced today that its strategic alliance with Celgene has reached a first milestone triggering revenues of $ 5.0 m to Evotec, which are recognised in the third quarter of 2017. The milestone is due to the successful completion of a screening campaign using Evotec’s induced...



Contact us


Business Development

T +44.(0)1235.86 15 61 T +1.732 329 2355 x3308